FAP and pancreatic neoplasm: Targeting specific stromal components, for example by inhibiting fibroblast activation protein (FAP), which was previously shown to reduce stromatogenesis in KRAS driven tumors of different tissues [305], may also reduce the stimulatory effect of the micro-environment on pancreatic tumors.